Memory Disorders Clinical Trial
Official title:
Replica Study of a Neuropsychological Treatment for Patients Who Show Spontaneous Confabulation After Acquired Brain Injury
NCT number | NCT03183453 |
Other study ID # | Conf-02 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | July 2015 |
Est. completion date | January 31, 2018 |
Verified date | May 2018 |
Source | San Rafael University Hospital, Granada, Spain |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Confabulators consistently generate false memories without intention to deceive and with
great feeling of rightness. However, there is currently no known effective treatment for
them. In order to fill this gap, we performed a neuropsychological treatment in two groups of
confabulators: experimental vs. control (ClinicalTrials.gov ID: NCT02540772).
Now, we intend to replicate the treatment with a larger sample of confabulators and with
other two control groups: non-confabulator patients with brain injury and healthy individuals
Status | Completed |
Enrollment | 57 |
Est. completion date | January 31, 2018 |
Est. primary completion date | September 1, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 35 Years to 80 Years |
Eligibility |
Inclusion Criteria: - The presence of spontaneous confabulations after acute brain injury, for at least three months and without clinical improvement (interfering with the patient's daily life with frequent arguments and exhaustive supervision). - The presence of momentary confabulations in the Spanish adaptation of Dalla Barba provoked confabulation interview. - Prior to injury, all patients should be completely independent for daily living. Exclusion Criteria: - The presence of impairment in alertness. - Dementia. - Acute confusional state. - A history of drug abuse. - Psychiatric antecedents. |
Country | Name | City | State |
---|---|---|---|
Spain | San Rafael University Hospital | Granada |
Lead Sponsor | Collaborator |
---|---|
Monica Triviño Mosquera |
Spain,
Ciaramelli E, Ghetti S, Borsotti M. Divided attention during retrieval suppresses false recognition in confabulation. Cortex. 2009 Feb;45(2):141-53. doi: 10.1016/j.cortex.2007.10.006. Epub 2008 Feb 6. — View Citation
Gilboa A, Alain C, Stuss DT, Melo B, Miller S, Moscovitch M. Mechanisms of spontaneous confabulations: a strategic retrieval account. Brain. 2006 Jun;129(Pt 6):1399-414. Epub 2006 Apr 25. — View Citation
Nahum L, Bouzerda-Wahlen A, Guggisberg A, Ptak R, Schnider A. Forms of confabulation: dissociations and associations. Neuropsychologia. 2012 Aug;50(10):2524-34. doi: 10.1016/j.neuropsychologia.2012.06.026. Epub 2012 Jul 7. — View Citation
Schnider A. The confabulating mind. How the brain creates reality. Oxford: Oxford University Press; 2008
Triviño M, Ródenas E, Lupiáñez J, Arnedo M. Effectiveness of a neuropsychological treatment for confabulations after brain injury: A clinical trial with theoretical implications. PLoS One. 2017 Mar 3;12(3):e0173166. doi: 10.1371/journal.pone.0173166. eCollection 2017. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in the number of Confabulations | The confabulations recorded were 1) guessed answers, 2) confusions in time and space, 3) a mixture of two or more stimuli presented, and 4) devised or bizarre responses. Scores ranged from 0 (no confabulations) to unlimited number of them (because devised or bizarre responses were recorded) and consisted of the sum of all the confabulations produced during the 3 sessions. |
A first measure (pre-treatment) was recorded after the recruitment up maximum to 1 month. A second measure (post-treatment) after 3 weeks (that was the duration of the treatment). | |
Primary | Change in the number of correct responses | Scores ranged from 0 (no correct answers) to 72 (12 stimuli remembered twice in each session: firstly, in a immediate recall after learning, and secondly, in a delayed recall after 10 minutes). | A first measure (pre-treatment) was recorded after the recruitment up maximum to 1 month. A second measure (post-treatment) after 3 weeks (that was the duration of the treatment). | |
Primary | Change in the number of non-responses | Scores ranged from 0 (no non-responses) to 72 (12 stimuli remembered twice in each session: firstly, in a immediate recall after learning, and secondly, in a delayed recall after 10 minutes). | A first measure (pre-treatment) was recorded after the recruitment up maximum to 1 month. A second measure (post-treatment) after 3 weeks (that was the duration of the treatment). | |
Secondary | Change in the number of errors in source attribution | After the recall of the material, patients were also asked to remember which modality corresponded to each recall (i.e., seen, heard or imagined), and who had presented the material during the learning session (i.e., the therapist or themselves). Scores ranged from 0 (if all answers were non-responses) to unlimited number (depending on number of confabulations produced by patients). |
A first measure (pre-treatment) was recorded after the recruitment up maximum to 1 month. A second measure (post-treatment) after 3 weeks (that was the duration of the treatment). |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03894254 -
Predictive Factors of Autonomy Loss in Real-life Cohort
|
N/A | |
Not yet recruiting |
NCT03507985 -
Attention and Memory Disorders Related to Acute Morphine
|
||
Terminated |
NCT02521558 -
Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's Disease
|
N/A | |
Completed |
NCT00355498 -
Amyloid Plaque and Tangle Imaging in Aging and Dementia
|
||
Completed |
NCT00010920 -
Preventing Cognitive Decline With Alternative Therapies
|
Phase 3 | |
Not yet recruiting |
NCT04079075 -
Multiple Interventions to Prevent Cognitive Decline
|
N/A | |
Completed |
NCT02185222 -
Effect of Vitamin D on Cognitive Decline of Patients With Memory Complaint
|
Phase 3 | |
Completed |
NCT00289471 -
Identifying Patients With Dementia in Primary Care
|
N/A | |
Terminated |
NCT00548327 -
The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype
|
Phase 2 | |
Completed |
NCT00403507 -
Exercise Treatment of Mild-Stage Probable Alzheimer's Disease
|
Phase 2 | |
Completed |
NCT00387062 -
Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment
|
Phase 1 | |
Completed |
NCT04587583 -
WeCareAdvisor: A Web-Based Tool to Improve Quality of Life for Military Veterans With Dementia and Their Caregivers
|
Phase 1/Phase 2 | |
Completed |
NCT02843529 -
Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI)
|
N/A | |
Active, not recruiting |
NCT03205709 -
Cognitive Training and Neuroplasticity in Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT05509075 -
Nutraceuticals and Functional Foods
|
||
Recruiting |
NCT05065450 -
Amygdala Memory Enhancement
|
N/A | |
Recruiting |
NCT05929144 -
Optimization of MRI Sequences Used in the Study of Neurodegenerative Diseases
|
N/A | |
Active, not recruiting |
NCT03661034 -
Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)
|
N/A | |
Completed |
NCT02333942 -
Dementia Signal Development Study of Nautilus NeuroWave TM for the Detection of Dementia
|
||
Completed |
NCT02236416 -
Physical Exercise for Prevention of Dementia
|
N/A |